Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DXB2MO
|
||||
| Drug Name |
2-Methyl-5-(5-methyl-pyrrolo[2,1-f][1,2,4]triazin-4-ylamino)-phenol
|
||||
| Synonyms |
CHEMBL188522
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C14H14N4O
|
||||
| Canonical SMILES |
Cc1ccc(Nc2ncnn3ccc(C)c23)cc1O
|
||||
| InChI |
InChI=1S/C14H14N4O/c1-9-3-4-11(7-12(9)19)17-14-13-10(2)5-6-18(13)16-8-15-14/h3-8,19H,1-2H3,(H,15,16,17)
|
||||
| InChIKey |
ATRMGRIXDIZXRO-UHFFFAOYSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | Vascular endothelial growth factor receptor 2 | Target Info | [1587926] | ||
| Epidermal growth factor receptor III | Target Info | [1587926] | |||
| NetPath Pathway | IL2 Signaling Pathway | ||||
| PANTHER Pathway | Angiogenesis | ||||
| VEGF signaling pathway | |||||
| Pathway Interaction Database | HIF-2-alpha transcription factor network | ||||
| Beta3 integrin cell surface interactions | |||||
| Signaling events mediated by TCPTP | |||||
| SHP2 signaling | |||||
| S1P1 pathway | |||||
| VEGF and VEGFR signaling network | |||||
| Integrins in angiogenesis | |||||
| Signaling events mediated by VEGFR1 and VEGFR2 | |||||
| Notch-mediated HES/HEY network | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.